Stephen Willard
Chief Executive Officer at NRX PHARMACEUTICALS, INC.
Net worth: 495 600 $ as of 2024-03-30
Profile
Stephen H.
Willard is currently the Chief Executive Officer, Secretary & Director at NRX Pharmaceuticals, Inc. He is also a Director at Global Life Technologies Corp.
Previously, he served as the Chief Executive Officer & Director at Cellphire, Inc. from 2013 to 2021.
He was the Non-Executive Chairman at Flamel Technologies SA from 2012 to 2014 and an Independent Director at E*TRADE Financial Corp.
from 2012 to 2014.
He also served as a Director at E*TRADE Bank from 2000 to 2014.
Additionally, he held the position of Associate Director-Resolutions at the Federal Deposit Insurance Corp.
He was a Director at ETB Holdings, Inc. in 2005 and served as the President of Flamel Technologies, Inc. Mr. Willard received his graduate degree from Yale University in 1985 and his undergraduate degree from Williams College in 1982.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-06 | 1,050,000 ( 1.14% ) | 495 600 $ | 2024-03-30 |
Stephen Willard active positions
| Companies | Position | Start |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Chief Executive Officer | 2022-07-11 |
Global Life Technologies Corp.
 Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | Director/Board Member | - |
Former positions of Stephen Willard
| Companies | Position | End |
|---|---|---|
Cellphire, Inc.
 Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Chief Executive Officer | 2021-02-28 |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Chairman | 2014-07-01 |
| E*TRADE FINANCIAL, LLC | Director/Board Member | 2014-05-05 |
E*TRADE Bank
 E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | Director/Board Member | 2013-12-31 |
ETB Holdings, Inc.
 ETB Holdings, Inc. Financial ConglomeratesFinance Part of Morgan Stanley, ETB Holdings, Inc. operates as a bank holding private company. The company is based in Arlington, VA. | Director/Board Member | 2005-03-31 |
Training of Stephen Willard
| Yale University | Graduate Degree |
| Williams College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
E*TRADE Financial Corp.
 E*TRADE Financial Corp. Investment Banks/BrokersFinance E*TRADE Financial Corp. engages in the provision of investment and online stock brokerage services. It offers digital platforms and support to individual investors through phone, email, and online via two national financial centers, and in-person at regional financial centers. The company was founded by William A. Porter Jr. and Bernard A. Newcomb in 1982 and is headquartered in Arlington, VA. | Finance |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | Finance |
Federal Deposit Insurance Corp.
 Federal Deposit Insurance Corp. Multi-Line InsuranceFinance Federal Deposit Insurance Corp. operates as an independent insurance agency. It offers insuring deposits, examining and supervising financial institutions for safety and soundness and consumer protection, making large and complex financial institutions resolvable, and managing receiverships. The company was founded in 1933 and is headquartered in Washington, DC. | Finance |
ETB Holdings, Inc.
ETB Holdings, Inc. Financial ConglomeratesFinance Part of Morgan Stanley, ETB Holdings, Inc. operates as a bank holding private company. The company is based in Arlington, VA. | Finance |
| Flamel Technologies, Inc. | |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Health Technology |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Stephen Willard
